vimarsana.com

“The pain of very large corporate NPAs that they recognised over the last four-five years has now gone away and they are going through a period of normalisation. We are a little more comfortable with the higher-quality PSUs and I think SBI clearly stands out out there.”

Related Keywords

India ,Sashi Anand ,Aurobindo Pharma ,Natco Pharma ,Glenmark Pharma , ,Valcreate Investment ,Psu Stocks ,Defence Stocks ,Stock Market ,Sectoral Plays ,Stock Market Investing ,Sbi ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.